Iridium‐Catalyzed Enantioselective Hydrogenation of Terminal Alkenes | Zendy

McIntyre Steven | Zendy; Hörmann Esther | Zendy; Menges Frederik | Zendy; Smidt Sebastian P. | Zendy; Pfaltz Andreas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Iridium‐Catalyzed Enantioselective Hydrogenation of Terminal Alkenes

Author(s) -

McIntyre Steven,

Hörmann Esther,

Menges Frederik,

Smidt Sebastian P.,

Pfaltz Andreas

Publication year - 2005

Publication title -

advanced synthesis and catalysis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.541

H-Index - 155

eISSN - 1615-4169

pISSN - 1615-4150

DOI - 10.1002/adsc.200404256

Subject(s) - iridium , chemistry , enantioselective synthesis , catalysis , aryl , asymmetric hydrogenation , oxazoline , ligand (biochemistry) , spin isomers of hydrogen , hydrogen , organic chemistry , medicinal chemistry , alkyl , biochemistry , receptor

Iridium complexes derived from chiral P,N ligands are efficient catalysts for the enantioselective hydrogenation of 2‐aryl‐substituted terminal alkenes. Using 0.1–1 mol % of catalyst at room temperature and ambient hydrogen pressure, high enantioselectivities (88–94% ee), full conversions after short reaction times and essentially quantitative yields were obtained for a range of differently substituted 2‐arylalkenes. Among six iridium complexes that were tested, the most selective catalyst was a complex with a phosphinite‐oxazoline ligand derived from threonine (Ir‐ThrePHOX). In contrast to the hydrogenation of trisubstituted alkenes, a strong pressure effect was observed for this class of substrates. Lowering the hydrogen pressure from 50 to 1 bar resulted in a strong increase of the ee values.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research